+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression



Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression



Journal of Innate Immunity 3(6): 631-638



Stimulation of Toll-like receptor 9 (TLR9) has been linked to invasion in various cancer cells in vitro. We investigated TLR9 expression in normal, dysplastic and malignant esophageal squamous epithelium. TLR9 expression was analyzed by immunohistochemistry in 46 cases of esophageal squamous cell carcinoma, including 12 cases with adjacent squamous dysplasia and 24 cases with normal esophageal epithelium. TLR9 expression was compared with tumor grade, stage, proliferation, apoptosis and vascular density. In normal esophageal squamous epithelium, TLR9 staining intensity decreased linearly from the basal layers to the superficial layers (p < 0.001). Strong TLR9 expression was detected across full thickness of high-grade dysplasia, the intensity clearly differing from the normal squamous epithelium and squamous cell carcinoma (p < 0.001). All squamous cell carcinomas exhibited TLR9 expression that was positively associated with a high grade (p < 0.05), the presence of lymph node metastases (p < 0.05) and previously undetected distant metastases (p < 0.05). Expression of TLR9 in the basal parts of normal esophageal epithelium suggests a role related to cell proliferation and differentation. TLR9 upregulation detected in dysplastic epithelium and in disseminated carcinomas indicates that this protein may serve as a novel marker for esophageal squamous dysplasia and carcinoma with metastatic potential.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056600609

Download citation: RISBibTeXText

PMID: 21876325

DOI: 10.1159/000329115


Related references

ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma. Human Pathology 46(5): 707-715, 2015

P53 expression in esophageal dysplasia - a possible biomarker for carcinogenesis of esophageal squamous-cell carcinoma. International Journal of Oncology 4(5): 1061-1065, 1994

Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. International Journal of Oncology 16(2): 261-266, 2000

Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma. Gastroenterology Clinics of North America 36(4): 797-811, V-Vi, 2007

Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiology, Biomarkers and Prevention 22(4): 540-552, 2013

Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences 16(11): 27824-27834, 2016

The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma. Cancer Prevention Research 9(7): 558-566, 2017

Identification of Novel Circulating MicroRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia. Cancer Epidemiology, Biomarkers and Prevention 2019, 2019

Predicting the risk of squamous dysplasia and esophageal squamous cell carcinoma using minimum classification error method. Computers in Biology and Medicine 45: 51-57, 2014

Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions. Annals of the New York Academy of Sciences 2018, 2018

Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prevention Research 1(5): 357-361, 2009

A variable structure fuzzy neural network model of squamous dysplasia and esophageal squamous cell carcinoma based on a global chaotic optimization algorithm. Journal of Theoretical Biology 318: 164-172, 2013

Squamous dysplasia is the histologic precursor of invasive esophageal squamous cell carcinoma results from a 13 year prospective follow up study in a high risk population. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1044, 2003

Squamous dysplasia is the histologic precursor of invasive esophageal squamous cell carcinoma: results from a 13-year prospective follow-up study in a high-risk population. Gastroenterology 124(4): A297-A298, 2003

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. American Journal of Pathology 162(6): 1789-1806, 2003